Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justine Decroocq

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|August 18, 2021
Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemiaJérémie Zerbit, Jerome Tamburini, Lauriane Goldwirt, et al.
Bone Marrow Transplantation|August 8, 2018
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-CalmettesLing Wang, Raynier Devillier, Ming Wan, et al.
International Journal of Laboratory Hematology|July 6, 2022
PCR-Fluo-ASXL1-FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignanciesChloé Friedrich, Loria Zalmaï, Juliette Gay, et al.
Blood Cells, Molecules & Diseases|November 9, 2021
Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challengeAmel Kime, Claire Bréal, Anne-Ségolène Cottereau, et al.
Viruses|November 11, 2022
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron EraJeremie Zerbit, Marion Detroit, Antoine Meyer, et al.
Haematologica|January 7, 2021
APR-246 induces early cell death by ferroptosis in acute myeloid leukemiaRudy Birsen, Clement Larrue, Justine Decroocq, et al.
Haematologica|March 30, 2023
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective studyNatacha Johnson, Marie Templé, Chloe Friedrich, et al.
The Lancet. Haematology|July 31, 2025
Prevention and management of infectious diseases in pregnant women with haematological malignanciesSébastien Gaultier, Asmaa Tazi, Caroline Charre, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Yannick Dieudonné, Stéphane Hilliquin, et al.
British Journal of Haematology|May 4, 2026
High frequency of CD95<sup>+</sup>/CD45RA<sup>-</sup> regulatory T cells defines an immunosuppressive profile associated with MDS progressionRomain Vazquez, Nicolas Deredec, Ismael Boussaid, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|August 18, 2021
Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemiaJérémie Zerbit, Jerome Tamburini, Lauriane Goldwirt, et al.
Bone Marrow Transplantation|August 8, 2018
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-CalmettesLing Wang, Raynier Devillier, Ming Wan, et al.
International Journal of Laboratory Hematology|July 6, 2022
PCR-Fluo-ASXL1-FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignanciesChloé Friedrich, Loria Zalmaï, Juliette Gay, et al.
Blood Cells, Molecules & Diseases|November 9, 2021
Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challengeAmel Kime, Claire Bréal, Anne-Ségolène Cottereau, et al.
Viruses|November 11, 2022
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron EraJeremie Zerbit, Marion Detroit, Antoine Meyer, et al.
Haematologica|January 7, 2021
APR-246 induces early cell death by ferroptosis in acute myeloid leukemiaRudy Birsen, Clement Larrue, Justine Decroocq, et al.
Haematologica|March 30, 2023
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective studyNatacha Johnson, Marie Templé, Chloe Friedrich, et al.
The Lancet. Haematology|July 31, 2025
Prevention and management of infectious diseases in pregnant women with haematological malignanciesSébastien Gaultier, Asmaa Tazi, Caroline Charre, et al.
Annals of the Rheumatic Diseases|March 6, 2026
Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Yannick Dieudonné, Stéphane Hilliquin, et al.
British Journal of Haematology|May 4, 2026
High frequency of CD95<sup>+</sup>/CD45RA<sup>-</sup> regulatory T cells defines an immunosuppressive profile associated with MDS progressionRomain Vazquez, Nicolas Deredec, Ismael Boussaid, et al.
Pageof 5